Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.
Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.
Jan Willem Popma
Director, Ace Pharmaceuticals BV
Talk to the deal team
Kardan Real Estate has issued bonds
Kardan Real Estate Ltd. has completed a fundraising to develop the business.Learn more
Argon Corporation has been acquired by Spectra
The private shareholders of Argon Corporation have sold the company to Spectra Aerospace and Defense, LLC (Spectra), a platform formed by Vance Street Capital.Learn more
Commercial Tube Processing has been acquired by Nelson Global Products
Tube Processing Corporation has sold its division Commercial Tube Processing (CTP) to Nelson Global Products Inc.Learn more